Vitamin D-binding protein levels in female patients with primary hyperparathyroidism.

OBJECTIVE To determine whether low levels of vitamin D-binding protein (DBP) are related to 25-hydroxyvitamin D (25[OH]D) deficiency in female patients with primary hyperparathyroidism (PHPT). METHODS Twenty-five female patients with PHPT (serum calcium level >10.2 mg/dL and intact parathyroid hormone (iPTH) level >66 pg/mL) and 25 healthy age- and body mass index-matched female control subjects were xaminod. Serum calcium and iPTH levels were determined by commercial laboratories. Levels of 25(OH)D and 1,25-dihydroxyvitamin D (1,25[OH]₂D) were determined by radioimmunoassay, and DBP level was determined by enzyme-linked immunosorbent assay. RESULTS Serum iPTH and calcium levels were higher in PHPT patients than control subjects (P<.001). Levels of 25(OH)D, albumin, and DBP were lower in the serum of PHPT patients than control subjects (P<.01). There were no significant differences in 1,25(OH)₂D and free 25(OH)D levels between PHPT patients and control subjects. DBP level was inversely correlated with calcium (r = -0.47; P<.01) and iPTH (r = -0.31; P<.05) levels. The 25(OH)D level correlated positively with both DBP (r = 0.28; P<.05) and albumin (r = 0.44; P<.05) levels. CONCLUSION Both serum 25(OH)D and DBP levels were lower in female patients with PHPT compared with control subjects. We suggest that a low DBP level contributes to the low 25(OH)D level observed in female PHPT patients. The etiology of the decrease in DBP and its relationship to calcium, 25(OH)D, and PTH levels require further investigation.

[1]  D. Albanes,et al.  Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. , 2012, Cancer research.

[2]  J. Adams,et al.  Vitamin D Binding Protein and Monocyte Response to 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D: Analysis by Mathematical Modeling , 2012, PloS one.

[3]  J. Manson,et al.  Serum 25‐hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: The women's health initiative (WHI) , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  J. She,et al.  Reduced Serum Vitamin D–Binding Protein Levels Are Associated With Type 1 Diabetes , 2011, Diabetes.

[5]  L. Mosekilde,et al.  Mild primary hyperparathyroidism and metabolism of vitamin D , 2011 .

[6]  G. Lärfars,et al.  Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  A. Goodman,et al.  Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[8]  G. Cockrell,et al.  Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? , 2011, The Journal of clinical endocrinology and metabolism.

[9]  S. Shapses,et al.  The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity. , 2011, The Journal of clinical endocrinology and metabolism.

[10]  I. Bhan,et al.  Vitamin D–Binding Protein Modifies the Vitamin D–Bone Mineral Density Relationship , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  R. Anderson,et al.  Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat. , 2010, American journal of physiology. Endocrinology and metabolism.

[12]  L. Mosekilde,et al.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.

[13]  I. Reid,et al.  Age‐, gender‐, and weight‐related effects on levels of 25‐hydroxyvitamin D are not mediated by vitamin D binding protein , 2007, Clinical endocrinology.

[14]  Pedro R Cutillas,et al.  Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. , 2007, American journal of physiology. Renal physiology.

[15]  J. Souberbielle,et al.  A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism , 2006, Journal of endocrinological investigation.

[16]  I. Reid,et al.  Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  P. White,et al.  The Multifunctional Properties and Characteristics of Vitamin D-binding Protein , 2000, Trends in Endocrinology & Metabolism.

[18]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[19]  K. Colston,et al.  Studies on vitamin D binding protein in the nephrotic syndrome. , 1985, Clinical chemistry.